The dendritic cell–tumor cross-talk in cancer
- 1 February 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 23 (1) , 146-152
- https://doi.org/10.1016/j.coi.2010.09.008
Abstract
No abstract availableKeywords
Funding Information
- INFLA-CARE FP7 EU grant, INCa, Fondation pourl a Recherche Médicale, Fondation de France
- China Scholarship Council
This publication has 63 references indexed in Scilit:
- Lipid accumulation and dendritic cell dysfunction in cancerNature Medicine, 2010
- Chemotherapy and radiotherapy: Cryptic anticancer vaccinesPublished by Elsevier ,2010
- Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXRImmunity, 2009
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid PhagocytosisCell, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Identification of a dendritic cell receptor that couples sensing of necrosis to immunityNature, 2009
- The Janus face of dendritic cells in cancerOncogene, 2008
- Identification of Tim4 as a phosphatidylserine receptorNature, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction SignalCell, 2003